{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T14:31:52Z","timestamp":1763389912768,"version":"3.40.5"},"reference-count":10,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","dldjournalonline.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Digestive and Liver Disease"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.dld.2024.08.048","type":"journal-article","created":{"date-parts":[[2024,9,10]],"date-time":"2024-09-10T04:46:40Z","timestamp":1725943600000},"page":"2172-2173","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Addressing the safety and efficacy of tofacitinib in ulcerative colitis: A response to the TOFA-UC study"],"prefix":"10.1016","volume":"56","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-6839-3289","authenticated-orcid":false,"given":"Maryam","family":"Shahid","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-1164-4120","authenticated-orcid":false,"given":"Isma","family":"Farid","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-1458-5941","authenticated-orcid":false,"given":"Maryum","family":"Shahzad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.dld.2024.08.048_bib0001","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.dld.2023.08.061","article-title":"Safety and effectiveness of tofacitinib in ulcerative colitis: data from TOFA-UC, a SN-IBD study","volume":"56","author":"Macaluso","year":"2024","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.dld.2024.08.048_bib0002","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1097\/MPG.0000000000003616","article-title":"Tofacitinib salvage therapy for children hospitalized for corticosteroid- and biologic-refractory ulcerative colitis","volume":"75","author":"Constant","year":"2022","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.dld.2024.08.048_bib0003","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/j.gastrohep.2023.09.013","article-title":"Tofacitinib en el tratamiento de la colitis ulcerosa moderada a grave en pacientes pedi\u00e1tricos colombianos: experiencia en mundo real","volume":"47","author":"Parra-Izquierdo","year":"2024","journal-title":"Gastroenterol Hepatol"},{"key":"10.1016\/j.dld.2024.08.048_bib0004","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1093\/ibd\/izad135","article-title":"Real-life efficacy of tofacitinib in various situations in ulcerative colitis: a retrospective worldwide multicenter collaborative study","volume":"30","author":"Res\u00e1l","year":"2024","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.dld.2024.08.048_bib0005","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.14309\/ajg.0000000000002263","article-title":"Comparative speed of early symptomatic remission with advanced therapies for moderate-to-severe ulcerative colitis: a systematic review and network meta-analysis","volume":"118","author":"Ahuja","year":"2023","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.dld.2024.08.048_bib0006","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.cgh.2022.04.038","article-title":"Superior effectiveness of tofacitinib compared to vedolizumab in anti-tnf-experienced ulcerative colitis patients: a nationwide dutch registry study","volume":"21","author":"Straatmijer","year":"2023","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.dld.2024.08.048_bib0007","article-title":"Peripheral Blood DNA methylation signatures and response to tofacitinib in moderate-to-severe ulcerative colitis","author":"Joustra","year":"2023","journal-title":"J Crohns Colitis"},{"key":"10.1016\/j.dld.2024.08.048_bib0008","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.1111\/j.1572-0241.2001.03944.x","article-title":"Impact of cessation of smoking on the course of ulcerative colitis","volume":"96","author":"Beaugerie","year":"2001","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.dld.2024.08.048_bib0009","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1007\/s00535-019-01589-3","article-title":"Dose\u2013response relationship between cigarette smoking and risk of ulcerative colitis: a nationwide population-based study","volume":"54","author":"Park","year":"2019","journal-title":"J Gastroenterol"},{"key":"10.1016\/j.dld.2024.08.048_bib0010","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1111\/apt.17248","article-title":"Effectiveness and safety of tofacitinib for ulcerative colitis: two-year results of the ICC Registry","volume":"57","author":"Straatmijer","year":"2023","journal-title":"Aliment Pharmacol Ther"}],"container-title":["Digestive and Liver Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S159086582400968X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S159086582400968X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,25]],"date-time":"2024-11-25T09:18:25Z","timestamp":1732526305000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S159086582400968X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":10,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["S159086582400968X"],"URL":"https:\/\/doi.org\/10.1016\/j.dld.2024.08.048","relation":{},"ISSN":["1590-8658"],"issn-type":[{"type":"print","value":"1590-8658"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Addressing the safety and efficacy of tofacitinib in ulcerative colitis: A response to the TOFA-UC study","name":"articletitle","label":"Article Title"},{"value":"Digestive and Liver Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.dld.2024.08.048","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.dld.2023.08.061","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Editrice Gastroenterologica Italiana S.r.l. Published by Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}